Emergence and identification of new products of designer drug products from the internet
Designer drugs represent a rapidly expanding phenomenon particularly facilitated by their Internet availability. These drugs are continuously emerging as analogues of controlled substances (amfetamine, aminoindane, cathinone, phencyclidine, etc...) and once an analogue has been banned; another replacement analogue appears on the market. They are often made in unlicensed laboratories which can result in their poor quality. This highlights the importance of analysing these products through detecting both their identity and purity. However, most of the analysis methods focused on emerging analogues of cathinone and very few studied other newer analogues such as phencyclidine derivatives. This is due partly to the regulations surrounding the analysis, the time consuming analytical procedures and the technical skills involved. Analysis of these designer drugs in the literature included both the identification of drug products and monitoring of products consistency over a period of time. In all cases, the results showed that these products may contain a range of a single or mixture of components including: a designer drug, a pharmaceutical active agent, an excipient or inorganic material.
Item Type | Article |
---|---|
Date Deposited | 26 Jul 2024 15:53 |
Last Modified | 26 Jul 2024 15:53 |
Explore Further
Read more research from the creator(s):
Find work associated with the faculties and division(s):
- Health & Human Sciences Research Institute
- Department of Pharmacy
- Centre for Clinical Practice, Safe Medicines and Drug Misuse Research
- Medicinal and Analytical Chemistry
- Natural Product Chemistry and Drug Design
- Centre for Research into Topical Drug Delivery and Toxicology
- Nanopharmaceutics
- Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Unit
- Department of Clinical, Pharmaceutical and Biological Science
- Centre for Health Services and Clinical Research
- School of Life and Medical Sciences
- Centre for Hazard Detection and Protection Research
- Centre for Research in Mechanisms of Disease and Drug Discovery
- Centre for Future Societies Research
Find other related resources:
- http://www.europeanpharmaceuticalreview.com/ [error in script]